Zealand Pharma A/S American Depositary Shares
ZEAL
ZEAL was delisted on the 29th of September, 2022.
16 hedge funds and large institutions have $47.9M invested in Zealand Pharma A/S American Depositary Shares in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
14% more funds holding
Funds holding: 14 → 16 (+2)
22% less capital invested
Capital invested by funds: $61.4M → $47.9M (-$13.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$164K |
| 2 |
BlackRock
New York
|
+$97.8K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$39.5K |
| 4 |
JP Morgan Chase
New York
|
+$9.73K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$9.66K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$6.23M |
| 2 |
Renaissance Technologies
New York
|
-$618K |
| 3 |
RA
Royce & Associates
New York
|
-$359K |
| 4 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
-$203K |
| 5 |
Morgan Stanley
New York
|
-$53.1K |
ZEAL Hedge Fund Activity: Q1 2021 in Review
16 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Zealand Pharma A/S American Depositary Shares (ZEAL) for Q1 2021, worth a combined $47.9M — down 22% from $61.4M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new ZEAL positions and 3 closed out — a net gain of 3 holders — while 5 added to existing stakes and 3 trimmed.
The largest buyer was Jane Street, adding an estimated $164K. The largest seller was Wellington Management Group, cutting an estimated $6.23M.
- 16 institutional investors held Zealand Pharma A/S American Depositary Shares (ZEAL) as of Q1 2021, up from 14 in Q4 2020.
- Funds reported $47.9M of Zealand Pharma A/S American Depositary Shares stock for Q1 2021, down 22% quarter-over-quarter.
- 6 funds opened new Zealand Pharma A/S American Depositary Shares positions in Q1 2021 and 3 closed out, a net change of +3 holders.
- The largest Zealand Pharma A/S American Depositary Shares buyer in Q1 2021 was Jane Street, an estimated $164K added.
- The largest Zealand Pharma A/S American Depositary Shares seller in Q1 2021 was Wellington Management Group, an estimated $6.23M sold.
Based on aggregated 13F filings for Q1 2021.